Back to Agenda
Session2
Session Chair(s)
Shohko Sekine
Reviewer, Office of New Drug IV
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Speaker(s)
S2-1
Kazuhiko Ishida, MSc, RPh
Astellas Pharma Inc., Japan
Director, Pharmacovigilance
S2-2
Kanae Ogiwara
Pfizer Japan Inc., Japan
Manager, Medical Compliance and Excellence
Have an account?